Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute

Patent Trial and Appeal Board Invalidates Agilent U.S. Patents 10,337,001 and 10,900,034 REDWOOD CITY, Calif., May 17, 2023 /PRNewswire/ -- Synthego Corp., a leading provider of genome engineering solutions, has announced a victory in its dispute with Agilent Technologies, Inc., regarding...

Click to view original post